Any company meeting the standards for the manufacture of unlicensed medicinal products, can supply cannabis-based products for medicinal use.<\/p>
Cannabis-based products for medicinal use are Schedule 2 controlled drugs under the Misuse of Drugs Regulations 2001, which means that manufacturers, importers and distributors of these products must hold valid Home Office and Medicines and Healthcare products Regulatory Agency (MHRA) licences for the relevant activities which will include possession, supply and production of controlled drugs. Where products are sourced from abroad, importers must obtain an import licence from the Home Office and the MHRA each time they import these products.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-22T15:41:10.24Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many UK companies have been issued with a licence to sell cannabis products for the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4390", "label" : {"_value" : "Biography information for Ian Blackford"} } , "tablingMemberConstituency" : {"_value" : "Ross, Skye and Lochaber"} , "tablingMemberPrinted" : [{"_value" : "Ian Blackford"} ], "uin" : "277762"} , {"_about" : "http://data.parliament.uk/resources/1139193", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139193/answer", "answerText" : {"_value" : "
My Rt. hon. Friend the Secretary of State for Health and Social Care has had numerous discussions with cabinet ministers to discuss a range of topics in advance of the Spending Review. Public health funding for 2020 onwards, including for HIV and sexual health services, will be considered carefully in the next Spending Review, in the light of the available evidence.<\/p>
It is for individual local authorities to decide their spending priorities based on an assessment of local need, including sexual health services, taking account of their statutory duties. Participation in the pre-exposure prophylaxis Impact Trial is on a voluntary basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "277793"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-22T15:40:08.913Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he is having with the Chancellor of the Exchequer on a long-term and sustainable funding package for the extension of PrEP trials.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4510", "label" : {"_value" : "Biography information for Helen Hayes"} } , "tablingMemberConstituency" : {"_value" : "Dulwich and West Norwood"} , "tablingMemberPrinted" : [{"_value" : "Helen Hayes"} ], "uin" : "277792"} , {"_about" : "http://data.parliament.uk/resources/1139194", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139194/answer", "answerText" : {"_value" : "
My Rt. hon. Friend the Secretary of State for Health and Social Care has had numerous discussions with cabinet ministers to discuss a range of topics in advance of the Spending Review. Public health funding for 2020 onwards, including for HIV and sexual health services, will be considered carefully in the next Spending Review, in the light of the available evidence.<\/p>
It is for individual local authorities to decide their spending priorities based on an assessment of local need, including sexual health services, taking account of their statutory duties. Participation in the pre-exposure prophylaxis Impact Trial is on a voluntary basis.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"} } , "answeringMemberConstituency" : {"_value" : "South Ribble"} , "answeringMemberPrinted" : {"_value" : "Seema Kennedy"} , "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "277792"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-07-22T15:40:08.96Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "HIV Infection: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chancellor of the Exchequer on a small investment for public health budgets to increase the provision for PrEP trials.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4510", "label" : {"_value" : "Biography information for Helen Hayes"} } , "tablingMemberConstituency" : {"_value" : "Dulwich and West Norwood"} , "tablingMemberPrinted" : [{"_value" : "Helen Hayes"} ], "uin" : "277793"} , {"_about" : "http://data.parliament.uk/resources/1139199", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1139199/answer", "answerText" : {"_value" : "
Funding for the multi-year (2018/19 \u2013 2020/21) Agenda for Change (AfC) pay and contract reform deal was confirmed alongside the Government\u2019s announcement via a Written Ministerial Statement (HCWS803<\/a>) laid before the House on 27 June 2018 that the Government was accepting the collectively agreed deal. This statement followed the previous Written Ministerial Statement (HCWS574<\/a>) laid before the house on 21 March 2018 in which additional funding for the AfC deal was committed to should trades union members agree to the deal.<\/p> In line with the Chancellor\u2019s commitment at Budget 2017, the Government released the £800 million already set aside to support the first year of the deal for 2018/19 in England.<\/p> Funding for the remaining two years of the deal (2019/20 and 2020/21) has been made available as part of the long-term funding settlement for the National Health Service.<\/p> <\/p> <\/p> <\/strong><\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-22T15:33:16.247Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Pay"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to paragraph 170 of his Department's Annual Report 2018-19 on the increased NHS resource budget and to the Written Statement on NHS Workforce made on 21 March 2018, HCWS574, if he will clarify when the additional £4.2 billion was agreed by the Chancellor for the NHS Agenda for Change three year pay deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4244", "label" : {"_value" : "Biography information for Jonathan Ashworth"}
}
, "tablingMemberConstituency" : {"_value" : "Leicester South"}
, "tablingMemberPrinted" : [{"_value" : "Jonathan Ashworth"}
], "uin" : "277749"}
, {"_about" : "http://data.parliament.uk/resources/1139200", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1139200/answer", "answerText" : {"_value" : " The Department has not assessed the potential benefits to public health of stopping the advertising of high sugar milk and milk-replacement products on public transport.<\/p> <\/p> As committed to in the second chapter of our childhood obesity plan, published in June 2018, the Department of Health and Social Care and the Department for Digital, Culture, Media and Sport have jointly consulted on introducing further advertising restrictions for products high in fat, sugar and salt (HFSS) on TV and online. As part of this consultation we invited views on whether the scope of this consultation should be extended to other forms of media and how HFSS products should be defined. We have received a high level of responses to the consultation and it is important we take the time to consider them carefully before we set out further action.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4455", "label" : {"_value" : "Biography information for Seema Kennedy"}
}
, "answeringMemberConstituency" : {"_value" : "South Ribble"}
, "answeringMemberPrinted" : {"_value" : "Seema Kennedy"}
, "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-22T15:44:18.183Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sugar: Advertising"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential benefits to public health of stopping the advertising of high sugar milk and milk-replacement products on public transport.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1463", "label" : {"_value" : "Biography information for Lord Watson of Wyre Forest"}
}
, "tablingMemberConstituency" : {"_value" : "West Bromwich East"}
, "tablingMemberPrinted" : [{"_value" : "Tom Watson"}
], "uin" : "277679"}
, {"_about" : "http://data.parliament.uk/resources/1139201", "AnsweringBody" : [{"_value" : "Ministry of Justice"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1139201/answer", "answerText" : {"_value" : " Responses to the two parts of the questions are as follows:<\/p> Part (a) - At this point it cannot be determined if the full data set for directly employed staff is available. The reason for this is because in Feb 2017 MOJ rationalised its payrolls and moved to a new payroll system (known as SOP), so any prior year\u2019s data, if available, would need to be sourced from legacy systems. To do this would require raising requests with several legacy suppliers who could then determine if the data was available. The cost of doing this would be disproportionate. Only data for the following financial periods are available. This data covers the MOJ group:<\/p> - February 2017 - March 2017 - £18,418,976<\/p> - April 2017 \u2013 March 2018 - £103,919,954<\/p> - April 2018 \u2013 March 2019 - £93,402,051<\/p> - April 2019 - June 2019 - £21,944,613<\/p> The average number of employees throughout the above periods was:<\/p> - In 2017 - 71,000<\/p> - In 2018 \u2013 72,000<\/p> - In 2019 \u2013 76,000<\/p> It should also be noted that there are many reasons why someone may get paid overtime, for example, in prisons for carrying out bedwatch or dealing with incidents of unrest. All of these elements have been included in the above figures.<\/p> <\/p> Part (b) \u2013 This data is not available because MOJ engage agency staff via third party providers such as Brook Street, and these staff are not on the MOJ payroll and therefore details of any overtime paid are not held by MOJ. MOJ pay for these individuals, who are generally charged out at an hourly rate, via invoice.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"}
}
, "answeringMemberConstituency" : {"_value" : "Charnwood"}
, "answeringMemberPrinted" : {"_value" : "Edward Argar"}
, "dateOfAnswer" : {"_value" : "2019-07-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-07-22T16:01:33.737Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "54"}
, "answeringDeptShortName" : {"_value" : "Justice"}
, "answeringDeptSortName" : {"_value" : "Justice"}
, "date" : {"_value" : "2019-07-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Ministry of Justice: Overtime"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Justice, how much his Department paid in overtime payments to (a) directly employed and (b) agency staff in each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4493", "label" : {"_value" : "Biography information for Richard Burgon"}
}
, "tablingMemberConstituency" : {"_value" : "Leeds East"}
, "tablingMemberPrinted" : [{"_value" : "Richard Burgon"}
], "uin" : "277786"}
, {"_about" : "http://data.parliament.uk/resources/1139207", "AnsweringBody" : [{"_value" : "Department for Work and Pensions"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1139207/answer", "answerText" : {"_value" : " The information requested is not readily available and to provide it would incur disproportionate cost.<\/p> <\/p> Informal observations form part of the suite of evidence used by Health Professionals at the face to face assessment to help Case Managers determine entitlement to benefit, along with medical evidence, history of conditions, social and occupational history, functional history including the \u2018typical day\u2019 and the functional examination.<\/p> <\/p> More information can be found at paragraph 1.6 in the Personal Independence Payment Assessment Guide at the following link:<\/p> <\/p>